{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:08:19Z","timestamp":1783109299398,"version":"3.54.6"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3744,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Antifungal prophylaxis has been proposed for liver transplant recipients at increased risk for invasive mold infection. Risk factors for invasive mold infection after liver transplantation were selected to divide recipients into 3 groups: (1) high risk\u2014transplantation on hemodialysis or delay of hospital discharge beyond day 7 after transplantation because of allograft or renal insufficiency; (2) intermediate risk\u2014retransplantation or transplantation for fulminant hepatic failure; (3) low risk\u2014absence of conditions in groups 1 and 2. During an intervention period (February 1999\u2013April 2001), prophylactic administration of a lipid complex of amphotericin (Abelcet) at 5 mg\/kg intravenously every 24 to 48 hours was recommended for high-risk recipients. The frequency of mold infection was compared to that of a preintervention period (February 1998\u2013January 1999) when antifungal prophylaxis was not provided. During the intervention period, invasive mold infection developed in 2 (6%) of 35 high-risk recipients, 0 of 28 intermediate-risk recipients, and 1 (0.5%) of 187 low-risk recipients. Overall, of 58 liver transplant recipients, 3 (5%) developed an invasive mold infection during the preintervention period, compared with 3 (1%) of 250 during the intervention period (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.08). The only death from invasive mold infection occurred during the preintervention period. Rates of pulse corticosteroid treatment of rejection and cytomegalovirus infection were lower during the intervention period. In conclusion, readily identifiable patient characteristics can be used to stratify liver transplant recipients for risk of invasive mold infection. Antifungal prophylaxis given to high-risk recipients may provide cost-effective prevention of these infections.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.20365","type":"journal-article","created":{"date-parts":[[2005,5,24]],"date-time":"2005-05-24T19:46:40Z","timestamp":1116964000000},"page":"656-662","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":50,"title":["Risk Stratification and Targeted Antifungal Prophylaxis for Prevention of Aspergillosis and Other Invasive Mold Infections After Liver Transplantation"],"prefix":"10.1097","volume":"11","author":[{"given":"Walter C.","family":"Hellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Bonatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Brumble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolland C.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Harnois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Spivey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery L.","family":"Steers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20250124","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF02114892","article-title":"Risk factors for systemic fungal infections in liver transplant recipients.","volume":"14","author":"Briegel","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R2-11-20250124","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/hep.1840210517","article-title":"Bacterial and fungal infections after liver transplantation: an analysis of 284 patients.","volume":"21","author":"Wade","year":"1995","journal-title":"Hepatology"},{"key":"R3-11-20250124","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/clinids\/24.2.179","article-title":"Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent.","volume":"24","author":"Singh","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R4-11-20250124","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/170.3.644","article-title":"Risk factors for invasive fungal infections complicating orthotopic liver transplantation.","volume":"170","author":"Collins","year":"1994","journal-title":"J Infect Dis"},{"key":"R5-11-20250124","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00005792-198803000-00006","article-title":"Infections after liver transplantation: an analysis of 101 consecutive cases.","volume":"67","author":"Kusne","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"R6-11-20250124","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archsurg.1991.01410260033005","article-title":"Clinical spectrum of fungal infections after orthotopic liver transplantation.","volume":"126","author":"Castaldo","year":"1991","journal-title":"Arch Surg"},{"key":"R7-11-20250124","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0002-9610(00)00366-4","article-title":"Association of fungal infection and increased mortality in liver transplant recipients.","volume":"179","author":"Rabkin","year":"2000","journal-title":"Am J Surg"},{"key":"R8-11-20250124","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199610150-00010","article-title":"Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation.","volume":"62","author":"Patel","year":"1996","journal-title":"Transplantation"},{"key":"R9-11-20250124","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/0003-4819-131-10-199911160-00003","article-title":"Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial.","volume":"131","author":"Winston","year":"1999","journal-title":"Ann Intern Med"},{"key":"R10-11-20250124","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00000658-197707000-00017","article-title":"Fungus infections after liver transplantation.","volume":"186","author":"Schroter","year":"1977","journal-title":"Ann Surg"},{"key":"R11-11-20250124","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007890-198510000-00002","article-title":"Fungal infections in liver transplant recipients.","volume":"40","author":"Wajszczuk","year":"1985","journal-title":"Transplantation"},{"key":"R12-11-20250124","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0891-5520(20)30714-5","article-title":"Fungal infections in solid organ transplant recipients.","volume":"9","author":"Hadley","year":"1995","journal-title":"Infect Dis Clin North Am"},{"key":"R13-11-20250124","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00007890-199709150-00009","article-title":"Invasive aspergillosis in liver transplant recipients in the 1990s.","volume":"64","author":"Singh","year":"1997","journal-title":"Transplantation"},{"key":"R14-11-20250124","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/313943","article-title":"Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy.","volume":"31","author":"Singh","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R15-11-20250124","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-200201150-00011","article-title":"Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices.","volume":"73","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"R16-11-20250124","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1097\/00007890-200206270-00009","article-title":"A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation.","volume":"73","author":"Hellinger","year":"2002","journal-title":"Transplantation"},{"key":"R17-11-20250124","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00007890-200209150-00017","article-title":"Randomized controlled trial of oral itraconazole solution versus intravenousoral fluconazole for prevention of fungal infections in liver transplant recipients.","volume":"74","author":"Winston","year":"2002","journal-title":"Transplantation"},{"key":"R18-11-20250124","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","article-title":"Risk factors for invasive aspergillosis in liver transplant recipients.","volume":"8","author":"Fortun","year":"2002","journal-title":"Liver Transpl"},{"key":"R19-11-20250124","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1086\/375219","article-title":"Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R20-11-20250124","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/345441","article-title":"Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients.","volume":"36","author":"Singh","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R21-11-20250124","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005792-199903000-00003","article-title":"Invasive aspergillosis in transplant recipients.","volume":"78","author":"Paterson","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"R22-11-20250124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R23-11-20250124","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0041-1345(98)00325-X","article-title":"Is liposomal amphotericin B (AmBisome) an effective prophylaxis of mycotic infections after liver transplantation?","volume":"30","author":"Braun","year":"1998","journal-title":"Transplant Proc"},{"key":"R24-11-20250124","first-page":"1195","article-title":"Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial.","volume":"27","author":"Tollemar","year":"1995","journal-title":"Transplant Proc"},{"key":"R25-11-20250124","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jlts.2000.7572","article-title":"Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.","volume":"6","author":"Singhal","year":"2000","journal-title":"Liver Transpl"},{"key":"R26-11-20250124","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00007890-200104150-00016","article-title":"Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy.","volume":"71","author":"Singh","year":"2001","journal-title":"Transplantation"},{"key":"R28-11-20250124","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1524-4733.2002.51108.x","article-title":"The direct cost and incidence of systemic fungal infections.","volume":"5","author":"Wilson","year":"2002","journal-title":"Value Health"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.20365","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200506000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:01:04Z","timestamp":1737734464000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200506000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.20365","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}